Výsledky vyhledávání - "Sofia Dahlqvist"

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Autor: Thomas Nyström, Erik Schwarz, Sofia Dahlqvist, Magnus Wijkman, Magnus Ekelund, Helen Holmer, Jan Bolinder, Jarl Hellman, Henrik Imberg, Irl B. Hirsch, Marcus Lind

Publikováno v: Journal of diabetes science and technology.

Background: People with type 1 diabetes generally view it easier to exercise when having continuous information of the glucose levels. We evaluated whether patients with type 1 diabetes managed with multiple daily insulin injections (MDI) exercised m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7c98cdb5dbc6b749d4c4bbbe5440137
https://pubmed.ncbi.nlm.nih.gov/35677967

Zobrazit plný text záznamu

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Autor: Jarl Hellman, Sofia Dahlqvist, Jan Bolinder, Tim Heise, Marcus Lind, Henrik Albrektsson, Magnus Wijkman, Aldina Pivodic, Irl B. Hirsch, Erik Schwarcz, William H. Polonsky, Arndís F. Ólafsdóttir

Publikováno v: Diabetes Care. 44:141-149

OBJECTIVE Continuous glucose monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in people with type 1 diabetes (T1D) treated with multiple daily insulin injections (MDI) when evaluated over shorter time periods. It is unclear to what exten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4f40324d8c33df629637ed30f9983c6
https://doi.org/10.2337/dc20-1468

Zobrazit plný text záznamu

Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes

Autor: Marcus Lind, Aso Saeed, Sofia Dahlqvist, Johan Mårtensson, Henrik Imberg, Sheyda Sofizadeh, Mary Dena, Irl B. Hirsch, Jaakko Tuomilehto, Magnus Wijkman, Ole Torffvit

Publikováno v: J Clin Hypertens (Greenwich)

Liraglutide is associated with blood pressure reduction in patients with type 2 diabetes. However, it is not known whether this blood pressure reduction can be predicted prior to treatment initiation, and to what extent it correlates with weight loss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90bae1e3886e70ce3db37999a35af3a
https://doi.org/10.1111/jch.13447

Zobrazit plný text záznamu

Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections

Autor: Klara Westman, Henrik Imberg, Magnus O. Wijkman, Irl B. Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Marcus Lind

Publikováno v: Journal of Diabetes and its Complications. 36:108110

In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a937d192b20ac7e932acbf00e40d18
https://doi.org/10.1016/j.jdiacomp.2021.108110

Zobrazit plný text záznamu

Sustained Intensive treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in persons with type 1 diabetes treated with MDI

Autor: William Polonsky, Tim Heise, Henrik Albrektsson, Erik Schwarcz, Magnus Wijkman, Jarl Hellman, Aldina Pivodic, Sofia Dahlqvist, Jan Bolinder, Irl B. Hirsch, Arndís F. Ólafsdóttir, Marcus Lind

Objective: Continuous Glucose Monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in persons with type 1 diabetes treated with multiple daily insulin injections (MDI) when evaluated over shorter time periods. It is unclear to what extent CG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35616713b262468d66dbbcbd227418c6
https://doi.org/10.2337/figshare.13042586.v1

Zobrazit plný text záznamu

Sustained Intensive Treatment and Long-term Effects on HbA

Autor: Marcus, Lind, Arndís F, Ólafsdóttir, Irl B, Hirsch, Jan, Bolinder, Sofia, Dahlqvist, Aldina, Pivodic, Jarl, Hellman, Magnus, Wijkman, Erik, Schwarcz, Henrik, Albrektsson, Tim, Heise, William, Polonsky

Publikováno v: Diabetes care. 44(1)

Continuous glucose monitoring (CGM) reduces HbAThe GOLD trial was a randomized crossover trial performed over 16 months of CGM treatment in people with T1D treated with MDI. People completing the trial (The primary end point of the change in HbAThe S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5a1df6f426605f667c84d225caf29b21
https://pubmed.ncbi.nlm.nih.gov/33199470

Zobrazit plný text záznamu

64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

Autor: Henrik Albrektsson, Marcus Lind, Tim Heise, Magnus Wijkman, Jarl Hellman, Aldina Pivodic, Erik Schwarcz, Jan Bolinder, William H. Polonsky, Irl B. Hirsch, Sofia Dahlqvist, Arndís F. Ólafsdóttir

Publikováno v: Diabetes. 69

CGM reduces A1c and time in hypoglycemia in persons with T1D treated with MDI evaluated over short time periods. It’s unclear to what extent CGM improves glucose control, treatment satisfaction, hypoglycemia fear and diabetes-related QoL long term.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa01ad446ee68fb6a6fa1c302c3a7137
https://doi.org/10.2337/db20-64-or

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání